Effect of B-GOS on GI Discomfort in Healthy Adults
Double-blind, Placebo Controlled, Randomised, Multicentered, of Parallel Design Study to Determine the Effect of B-GOS on GI Discomfort in Healthy Adults
1 other identifier
interventional
400
1 country
1
Brief Summary
The aim of the study is to evaluate the effects of a new food supplement which is currently available in the market, called Bimuno® (B-GOS), on gastrointestinal discomfort (e.g. bloating, abdominal pain/cramp and flatulence) in adults who often experience these symptoms but are otherwise healthy. About 400 volunteers will take part in this study, which will last 6 weeks (to include 4 weeks treatment and 2 weeks follow up period). Episodes of abdominal pain or discomfort (e.g. bloating, abdominal pain/cramp and flatulence), in the absence of diseases, are commonly associated with food or drug intake or with alterations of bowel habit and vary between individuals in frequency and severity. Some dietary ingredients are known to reduce these symptoms. We have used B-GOS previously in trials with healthy younger and older adults and we have observed a trend towards reducing abdominal bloating. However, the investigators have not tested B-GOS in healthy adults who often experience these symptoms and this is what we will investigate now.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 healthy
Started Feb 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 25, 2013
CompletedFirst Posted
Study publicly available on registry
April 5, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedNovember 27, 2013
April 1, 2013
9 months
February 25, 2013
November 26, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
To determine the effect of B-GOS on GI discomfort
questionnaires
Participants will be followed daily for 6 weeks
Secondary Outcomes (1)
To conduct an assessment of stools
Participants will be followed daily for 6 weeks.
Other Outcomes (1)
To assess the effect of B-GOS on the quality of life and general well being.
beginning and end of the study
Study Arms (2)
B-GOS
EXPERIMENTAL2.75g daily for 4 weeks
Maltodextrin
PLACEBO COMPARATOR2.75g daily for 4 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Aged between 18 and 65 years old.
- Presence of bloated feeling or experiencing abdominal fullness, with or without visible distention, often in the last 12 months.
- Ability to communicate well with the investigator and to comply with the requirements of the entire study.
- Volunteer has given written informed consent to participate and is willing to participate in the entire study.
You may not qualify if:
- History or evidence of organic disease of the gastrointestinal tract; such as tumour, irritable bowel syndrome, etc., within the previous 5 years.
- Undergone surgical resection of any part of the bowel.
- History of malignancy within the previous 5 years (with exception of well-treated basal cell carcinoma or in situ cervical carcinoma).
- Received antibiotics in the previous four weeks.
- Consumed probiotic or prebiotic preparations on a regular basis (at least 3 times per week) in the last 2 weeks.
- Former participation in another study involving prebiotic or probiotic preparations or investigational drugs within the previous one month, or intention to use such drugs during the course of the study.
- Severe allergy or any history of severe abnormal drug reaction, drug or alcohol abuse.
- Regular use of any medication with exception of hormonal replacement therapy and contraception.
- Women who are pregnant or breast-feeding.
- Fertile women not practicing a medically-approved method of contraception.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clasado Limitedlead
Study Sites (1)
Research Insights Ltd
Oxford, OX11 9LH, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2013
First Posted
April 5, 2013
Study Start
February 1, 2013
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
November 27, 2013
Record last verified: 2013-04